NASDAQ:ARDS

Aridis Pharmaceuticals Stock Signals

etoro logo Buy ARDS
*Your capital is at risk
$0.0002
+0 (+0%)
At Close: Nov 17, 2025

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.108 4 days ( 0 % )
Last Price $0.0002 0 %
High/ Low $0.0002 - $0.0002 0%
Chg 7 Days N/A $0.0002 $0.0002
Chg 30 Days N/A $0.0002 $0.0002
Chg 12 mos 100.00 % $0.0001000000 $0.0002
Trend - 3 mos 59.10 % Width: 2,354.34 %
Trend - 12 mos 34.35 % Width: 431.64 %
Pred. range - 3 mos $0.0002 - $0.0046 -5.90 % - 2,209.57 %
Pred. range - 12 mos N/A - $0.0036 -100.00 % - 1,678.93 %
Short MA avg 3 mos Buy Nov 10, 2025 - 6 days
Long MA avg 3 mos Buy Nov 10, 2025 - 6 days
Short/Long MA avg 3 mos Sell Nov 07, 2025 - 7 days
Short MA avg 12 mos Buy Nov 10, 2025 - 6 days
Long MA avg 12 mos Buy Nov 10, 2025 - 6 days
Short/Long MA avg 12 mos Buy Aug 19, 2025 - 64 days
Pivot Short Buy Nov 12, 2025 - 4 days
Bollinger Sell Nov 30, -0001 - N/A days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT ARIDIS PHARMACEUTICALS INC.
Aridis Pharmaceuticals
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin. The company is also developing AR-32...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE